[HTML] sciencedirect.com

[HTML][HTML] LC–MS/MS method for simultaneous quantification of ten antibiotics in human plasma for routine therapeutic drug monitoring

M Radovanovic, RO Day, GDR Jones, P Galettis… - Journal of Mass …, 2022 - Elsevier
Background Optimizing antimicrobial therapy to attain drug exposure that limits the
emergence of resistance, effectively treats the infection, and reduces the risk of side effects …
被引用次数：8 相关文章
[HTML] nih.gov

[HTML][HTML] LC–MS/MS method for simultaneous quantification of ten antibiotics in human plasma for routine therapeutic drug monitoring

M Radovanovic, RO Day, GDR Jones… - Journal of Mass …, 2022 - ncbi.nlm.nih.gov
Background Optimizing antimicrobial therapy to attain drug exposure that limits the
emergence of resistance, effectively treats the infection, and reduces the risk of side effects …
[PDF] scienceopen.com

[PDF][PDF] Advances in the Clinical Lab

M Radovanovic, RO Day, GDR Jones, P Galettis… - scienceopen.com
Background: Optimizing antimicrobial therapy to attain drug exposure that limits the
emergence of resistance, effectively treats the infection, and reduces the risk of side effects …

LC–MS/MS method for simultaneous quantification of ten antibiotics in human plasma for routine therapeutic drug monitoring

M Radovanovic, R Day, G Jones… - Journal of Mass …, 2022 - europepmc.org
Background Optimizing antimicrobial therapy to attain drug exposure that limits the
emergence of resistance, effectively treats the infection, and reduces the risk of side effects …

LC-MS/MS method for simultaneous quantification of ten antibiotics in human plasma for routine therapeutic drug monitoring

M Radovanovic, RO Day… - Journal of mass …, 2022 - pubmed.ncbi.nlm.nih.gov
Background Optimizing antimicrobial therapy to attain drug exposure that limits the
emergence of resistance, effectively treats the infection, and reduces the risk of side effects …